Literature DB >> 16876320

Correlation of tau gene polymorphism with age at onset of Parkinson's disease.

Hideaki Kobayashi1, Hiroshi Ujike, Junko Hasegawa, Mitsutoshi Yamamoto, Akihiro Kanzaki, Ichiro Sora.   

Abstract

Parkinson's disease (PD) is a neurodegenerative disease and its prevalence increases with age. The microtubule-associated protein tau (MAPT) is thought to be implicated in the pathogenesis of PD. Association of the MAPT H1 haplotype with PD in Caucasians has been extensively studied, however, the results were inconsistent. In this study, we investigated whether MAPT gene variants contribute to the pathogenesis process including the age at onset in Japanese PD. Promoter region of MAPT gene was analyzed to find polymorphisms in Japanese population. Two single nucleotide polymorphisms (SNPs), C-639T and Del-568TIns, in promoter region were found. C-639T was novel. Unlike Caucasians, the -226C and -45A alleles consisting of the H1 haplotype were monomorphic in Japanese population. Association analysis was performed using 240 PD and 191 controls in these SNPs. No significant association was observed between these SNPs and PD. Haplotype analysis also showed no significant association (P=0.72). However, the age at onset showed significant correlation with the genotypes of Del-568TIns in PD samples when analyzed by Kendall rank correlation test (Kendall tau=-0.098, P=0.0243). These results suggested that MAPT gene variants may modify the pathogenesis process of PD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876320     DOI: 10.1016/j.neulet.2006.06.057

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  PSP-Phenotype in SCA8: Case Report and Systemic Review.

Authors:  Makoto Samukawa; Makito Hirano; Kazumasa Saigoh; Shigeru Kawai; Yukihiro Hamada; Daisuke Takahashi; Yusaku Nakamura; Susumu Kusunoki
Journal:  Cerebellum       Date:  2019-02       Impact factor: 3.847

2.  Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.

Authors:  Albert A Davis; Kristin M Andruska; Bruno A Benitez; Brad A Racette; Joel S Perlmutter; Carlos Cruchaga
Journal:  Neurobiol Aging       Date:  2015-09-30       Impact factor: 4.673

3.  Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse.

Authors:  I Taes; A Goris; R Lemmens; M A van Es; L H van den Berg; A Chio; B J Traynor; A Birve; P Andersen; A Slowik; B Tomik; R H Brown; C E Shaw; A Al-Chalabi; S Boonen; L Van Den Bosch; B Dubois; P Van Damme; W Robberecht
Journal:  Neurology       Date:  2010-05-25       Impact factor: 9.910

4.  Family-based association analysis of the MAPT gene in Parkinson disease.

Authors:  K S Wang; J E Mullersman; X F Liu
Journal:  J Appl Genet       Date:  2010       Impact factor: 2.653

Review 5.  LRRK2 and Protein Aggregation in Parkinson's Disease: Insights From Animal Models.

Authors:  Dylan J Dues; Darren J Moore
Journal:  Front Neurosci       Date:  2020-07-08       Impact factor: 4.677

6.  Connectivity Analysis for Multivariate Time Series: Correlation vs. Causality.

Authors:  Angeliki Papana
Journal:  Entropy (Basel)       Date:  2021-11-25       Impact factor: 2.524

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.